A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

Clinical trial NCT02781727 · COMPLETED

Trial details

NCT number: NCT02781727
Sponsor: Ascendis Pharma Endocrinology Division A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Growth Hormone Deficiency, Pediatric hGH (Human Growth Hormone)Endocrine System Diseases Hormones Pituitary Diseases

Start date: 2016-12-13
Primary completion: 2019-01-17
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.